Net profit of Balaxi Pharmaceuticals declined 20.95% to Rs 8.64 crore in the quarter ended March 2025 as against Rs 10.93 crore during the previous quarter ended March 2024. Sales rose 27.48% to Rs 76.27 crore in the quarter ended March 2025 as against Rs 59.83 crore during the previous quarter ended March 2024.
For the full year,net profit declined 30.19% to Rs 25.07 crore in the year ended March 2025 as against Rs 35.91 crore during the previous year ended March 2024. Sales rose 21.25% to Rs 292.56 crore in the year ended March 2025 as against Rs 241.29 crore during the previous year ended March 2024.